MARKET PROFILE: Mongolia - Pharma’s Final Frontier?
This article was originally published in PharmAsia News
Mongolia is a country with a huge territory but relatively small population. In recent years, the country has developed rapidly because of its massive coking coal and copper deposits, with GDP growth of 7.8% in 2014. But what are the features, prospects and challenges for its healthcare industry?
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.